|
David J. Poston, Vice President, Finance, Chief Financial Officer, and Treasurer
David Poston joined Targeted Genetics Corporation in 1999 and served as the company’s senior director of finance and accounting from 2001 through 2005 and as the finance director from 1999 to 2001. Mr. Poston leads the operations of the finance and accounting groups, internal and SEC financial reporting, budgeting, project cost accounting, general accounting, internal financial controls, audit committee coordination, lease financing, treasury and insurance matters and financial aspects of corporate collaborations. Mr. Poston helped establish and later spin-off CellExSys, Inc., as a vehicle for capitalizing on Targeted Genetics’ cell therapy technologies, serving as secretary and treasurer of CellExSys from its founding in 2000 until its sale in 2004. Prior to joining Targeted Genetics, he served as controller of Corixa Corporation, controller and assistant treasurer of Todd Shipyards Corporation and in financial management capacities at Rocket Research Corporation (now General Dynamics). Mr. Poston has over twenty years of financial experience, has had primary responsibility for public company financial disclosure matters since 1993 and started his career in public accounting at KPMG in 1985. Mr. Poston graduated from the University of Puget Sound with a B.S. in accounting, a minor in mathematics and as the Norton Clapp Arete Scholar. | 